How much does it cost to take Mobosetinib/Mobosetinib for a month?

Mobocertinib/Mobocertinib is a targeted drug targeting epidermal growth factor receptor (EGFR) mutations and is mainly used to treat non-small cell lung cancer (NSCLC) with specific mutations. Especially for patients carrying the EGFR T790M mutation, mobosetinib has shown good efficacy and can effectively control tumor growth. Studies have shown that mobosetinib, as an oral drug, can block the proliferation signals of cancer cells by selectively inhibiting the activity of EGFR tyrosine kinase, thereby delaying disease progression and improving patients' quality of life and survival time.

In terms of dosage, the recommended dose for adult patients is 160 mg once daily until disease progression or unacceptable toxicity occurs. In clinical application, mobosetinib is generally suitable for patients who have received other treatments but whose disease is still progressing, especially those cases that are resistant to conventional EGFR inhibitors. The common specifications of moboxetinib on the market may be 40mg*112 capsules, and a patient will need about one box for one month’s use.

In the Chinese market, the original drug of moboxetinib has been launched, but it is not yet covered by medical insurance. The price of moboxetinib is approximately around RMB 40,000. In addition, in some areas, there is a 40mg clinical version of the drug, which sells for about more than 7,000 yuan. It is worth mentioning that there are also some generic drugs available in overseas markets. For example, a pharmaceutical factory in Laos produces a 40mg*120-tablet generic drug, which may cost only more than 4,000 yuan, which provides patients with more choices. However, due to the different sources and production processes of drugs, patients should be cautious when choosing generic drugs, and it is best to do so under the guidance of a doctor.